Align Technology Inc header image

Align Technology Inc

ALGN

Equity

ISIN null / Valor 1159441

NASDAQ (2026-03-27)

USD 166.38-6.17%

Align Technology Inc
UMushroom community rating:

4.50 2 votes No rating yet

NegativeNeutralPositive

About company

Align Technology Inc is a global leader in the dental CAD/CAM software market, offering fully integrated workflows to dental labs and practices through a wide network of partners and resellers in over 150 countries. The company's digital scanning technology, including the iTero intraoral scanner, complements its Invisalign system, enhancing patient scans and overall experience. Align Technology continues to invest in digital restorative workflows, with over 17 million restorative cases enabled by the iTero scanner to date. Additionally, the company provides a range of digitally enabled solutions for restorative dentistry, orthodontic treatment, and other dental applications. With a focus on innovation and customer satisfaction, Align Technology remains a leading provider of advanced clear aligner systems and digital orthodontic solutions worldwide.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

1.27%1Y

-45.6%3Y

-68.5%5Y

Performance

60.6%1Y

50.0%3Y

51.1%5Y

Volatility

11860 M

Market cap (USD)

1,294,114

Daily traded volume (Shares)

208.1 / 204.16

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.50

2 votes

Performance:

4.50

Innovation:

4.00

Society:

4.50

Nature:

4.00

Luba Schoenig

Switzerland, 29 May 2024

The market value of the dental aligners is set for fast growth

Lea Katunaric

Switzerland, 28 May 2024

Seems to be gaining interest and relevance as a beauty stock. I would keep an eye on it.

EQUITIES OF THE SAME SECTOR

Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals Inc Valor: 30877188

Annual Return

-50%0%+50%

Risk level

110

-2.82%USD 72.15

Intra-Cellular Therapies Inc

Intra-Cellular Therapies Inc Valor: 23194616

Annual Return

-50%0%+50%

Risk level

110

0.00%USD 131.87

Denali Therapeutics Inc

Denali Therapeutics Inc Valor: 39149539

Annual Return

-50%0%+50%

Risk level

110

-7.98%USD 18.16

GE Healthcare Technologies Inc

GE Healthcare Technologies Inc Valor: 123735674

Annual Return

-50%0%+50%

Risk level

110

-3.23%USD 69.23

Option Care Health Inc

Option Care Health Inc Valor: 52359365

Annual Return

-50%0%+50%

Risk level

110

-1.73%USD 27.27

Boiron SA

Boiron SA Valor: 487646

Annual Return

-50%0%+50%

Risk level

110

1.56%EUR 26.00

Laboratorios Farmaceuticos Rovi, SA

Laboratorios Farmaceuticos Rovi, SA Valor: 3591807

Annual Return

-50%0%+50%

Risk level

110

-0.57%EUR 78.90

Roche Holding Ltd

Roche Holding Ltd Valor: 1203204

Annual Return

-50%0%+50%

Risk level

110

-0.10%CHF 312.50

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc Valor: 33395434

Annual Return

-50%0%+50%

Risk level

110

-1.56%USD 510.68

Evotec SE

Evotec SE Valor: 505433

Annual Return

-50%0%+50%

Risk level

110

-1.60%EUR 4.30

SIX

FactSet

Clearbit

Logos provided by Clearbit